1. Home
  2. MSGY vs BMRA Comparison

MSGY vs BMRA Comparison

Compare MSGY & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSGY

Masonglory Limited Ordinary Shares

HOLD

Current Price

$0.43

Market Cap

6.0M

Sector

N/A

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$1.64

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSGY
BMRA
Founded
2018
1971
Country
Hong Kong
United States
Employees
9
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
7.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
MSGY
BMRA
Price
$0.43
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
562.4K
9.7K
Earning Date
03-31-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.64
52 Week High
$22.20
$4.60

Technical Indicators

Market Signals
Indicator
MSGY
BMRA
Relative Strength Index (RSI) 39.06 35.08
Support Level $0.41 N/A
Resistance Level $0.60 $2.23
Average True Range (ATR) 0.05 0.05
MACD -0.01 0.01
Stochastic Oscillator 14.66 26.88

Price Performance

Historical Comparison
MSGY
BMRA

About MSGY Masonglory Limited Ordinary Shares

Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: